DrugPatentWatch Database Preview
Details for Patent: 8,338,427
Email this page to a colleague
Which drugs does patent 8,338,427 protect, and when does it expire?
Patent 8,338,427 protects ABILIFY MAINTENA KIT and is included in one NDA.
This patent has twenty-nine patent family members in twenty-one countries.
Summary for Patent: 8,338,427
| Title: | Methods for administering aripiprazole |
| Abstract: | The present invention relates, in part, to the discovery that a pharmaceutical composition comprising aripiprazole and a carrier administered in a bolus injection resulted in an extended release profile similar to that obtained by the injection of a poly lactide-co-glycolide microsphere formulation containing the active agent. This surprising result suggests that pharmacologically beneficial extended release formulations without the complexities and expense associated with the manufacture microspheres. |
| Inventor(s): | Brown; Josiah (Seattle, WA) |
| Assignee: | Alkermes, Inc. (Waltham, MA) |
| Application Number: | 12/251,656 |
|
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 8,338,427
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | RX | Yes | No | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign up for a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | RX | Yes | No | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | Y | USE OF ARIPIPRAZOLE IN EXTENDED RELEASE INJECTABLE SUSPENSION IN TREATING ACUTE EPISODES OF SCHIZOPHRENIA | ⤷ Sign up for a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | Y | USE OF ARIPIPRAZOLE IN EXTENDED RELEASE INJECTABLE SUSPENSION IN TREATING ACUTE EPISODES OF SCHIZOPHRENIA | ⤷ Sign up for a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign up for a Free Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,338,427
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 522200 | ⤷ Sign up for a Free Trial | |||
| Australia | 2004264886 | ⤷ Sign up for a Free Trial | |||
| Canada | 2534997 | ⤷ Sign up for a Free Trial | |||
| China | 102133171 | ⤷ Sign up for a Free Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
